• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

PolyPid Ltd. - Ordinary Shares (NQ:PYPD)

5.190 UNCHANGED
Delayed Quote Updated: 4:00 PM EDT, Oct 2, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 0
Open 5.190
Bid (Size) 3.650 (100)
Ask (Size) 6.000 (200)
Prev. Close 5.190
Today's Range 5.190 - 5.190
52wk Range 3.060 - 5.730
Shares Outstanding 18,756,570
Dividend Yield N/A
Chart for  (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
News headline image
PolyPid Nears FDA Decision for D-PLEX100 After Strong Phase III Data ↗
October 04, 2026
PolyPid (NASDAQ:PYPD) is approaching a November 28 PDUFA date for D-PLEX100, its lead product candidate for preventing surgical site infections in patients undergoing colorectal surgery, Chief... 
Via MarketBeat
Topics Bonds
News headline image
PolyPid (PYPD) Q2 2026 Earnings Call Transcript ↗
August 19, 2026
FDA accepts D-PLEX100 application with Priority Review, setting November approval target. 
Via The Motley Fool
Topics Earnings

Performance

52-Week Range 9.4% below 52-week high
5.190
3.0652W Low 5.7352W High
1 Week 6.5% below 1-week high
5.061W Low 5.551W High

PolyPid Ltd. - Ordinary Shares (PYPD) traded between $3.06 and $5.73 over the past 52 weeks and last traded at $5.19, 9.4% below its 52-week high. Over the past week it ranged between $5.06 and $5.55.

Past 12 Months
-2.3%
-3.7%
-7.0%
+22.4%
+19.3%
+46.6%
1W -$0.12
1M -$0.20
3M -$0.39
6M +$0.95
YTD +$0.84
1Y +$1.65

PYPD was +46.6% over the past year, +22.4% over six months, +19.3% year to date, -2.3% in the last week.

12 Months vs Market
PYPD
+46.6%
DIA
+9.5%
SPY
+14.6%
QQQ
+23.3%
IWM
+14.1%

Over the past 12 months PYPD returned +46.6% versus DIA (Dow) +9.5%, SPY (S&P 500) +14.6%, QQQ (Nasdaq 100) +23.3% and IWM (Russell 2000) +14.1%.

Volume & Liquidity
1W
95.3K
1M
90.0K
3M
190.5K
6M
154.4K
YTD
123.4K
1Y
114.2K

PYPD's 3-month average daily volume is 190.5K.

More News

Read More
News headline image
PolyPid Q2 Earnings Call Highlights ↗
August 12, 2026
Via MarketBeat
Topics Earnings
PolyPid Ltd (NASDAQ:PYPD) Reports Q4 2025 Results, Focus on D-PLEX₁₀₀ Partnership and Regulatory Progress ↗
February 11, 2026
Via Chartmill
News headline image
Earnings Scheduled For November 12, 2025 ↗
November 12, 2025
Via Benzinga
News headline image
A Look Ahead: PolyPid's Earnings Forecast ↗
May 13, 2025
Via Benzinga
News headline image
PolyPid (PYPD) Q1 2026 Earnings Transcript ↗
May 13, 2026
Via The Motley Fool
News headline image
PolyPid Q1 Earnings Call Highlights ↗
May 13, 2026
Via MarketBeat
Topics Earnings
News headline image
PolyPid (PYPD) Q4 2025 Earnings Call Transcript ↗
February 11, 2026
Via The Motley Fool
Topics Earnings
News headline image
PolyPid Soars 3.4% on Pivotal FDA Endorsement for D-PLEX100 NDA
December 03, 2025
Via MarketMinute
An Overlooked Crisis in Hospitals Could Be Pharma’s Next Great Opportunity
October 13, 2025
Via AB Newswire
News headline image
These stocks are moving in today's pre-market session ↗
August 18, 2025
Via Chartmill
News headline image
12 Health Care Stocks Moving In Monday's Pre-Market Session ↗
August 18, 2025
Via Benzinga
News headline image
Cisco To Rally Around 21%? Here Are 10 Top Analyst Forecasts For Thursday ↗
August 14, 2025
Via Benzinga
News headline image
POLYPID LTD (NASDAQ:PYPD) Reports Q2 2025 Results with Mixed Market Reaction Despite Positive Phase 3 D-PLEX₁₀₀ Data ↗
August 13, 2025
Via Chartmill
PolyPid’s Game-Changing 60-Day GLP-1 Platform Could Disrupt $100B Weight Loss Market
July 15, 2025
Via AB Newswire
News headline image
With Fresh Funding and Strong Phase 3 Data, PolyPid Advances Towards FDA Approval
June 18, 2025
Via News Direct
News headline image
These stocks have an unusual volume in today's session ↗
June 10, 2025
Via Chartmill
News headline image
Nano-Cap PolyPid's Lead Drug Candidate Cuts Surgical Infection Risk by 38% In Phase 3 Trial ↗
June 09, 2025
Via Benzinga
News headline image
Earnings Scheduled For August 13, 2025 ↗
August 13, 2025
Via Benzinga
News headline image
Why Circle Internet Group Shares Are Trading Higher By Around 18%; Here Are 20 Stocks Moving Premarket ↗
June 09, 2025
Via Benzinga
News headline image
This Excelerate Energy Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Thursday ↗
June 05, 2025
Via Benzinga
News headline image
Q1 Virtual Investor Summit: On-Demand Presentations Now Live
March 18, 2025
Via ACCESS Newswire
News headline image
Earnings Scheduled For May 14, 2025 ↗
May 14, 2025
Via Benzinga
News headline image
PolyPid Ltd. to Present at the Q1 Investor Summit Virtual Conference on March 11th, 2025
February 27, 2025
Via ACCESS Newswire

Frequently Asked Questions

Is PolyPid Ltd. - Ordinary Shares publicly traded?
Yes, PolyPid Ltd. - Ordinary Shares is publicly traded.
What exchange does PolyPid Ltd. - Ordinary Shares trade on?
PolyPid Ltd. - Ordinary Shares trades on the Nasdaq Stock Market
What is the ticker symbol for PolyPid Ltd. - Ordinary Shares?
The ticker symbol for PolyPid Ltd. - Ordinary Shares is PYPD on the Nasdaq Stock Market
What is the current price of PolyPid Ltd. - Ordinary Shares?
The current price of PolyPid Ltd. - Ordinary Shares is 5.190
When was PolyPid Ltd. - Ordinary Shares last traded?
The last trade of PolyPid Ltd. - Ordinary Shares was at 10/02/26 04:00 PM ET
What is the market capitalization of PolyPid Ltd. - Ordinary Shares?
The market capitalization of PolyPid Ltd. - Ordinary Shares is 97.35M
How many shares of PolyPid Ltd. - Ordinary Shares are outstanding?
PolyPid Ltd. - Ordinary Shares has 97M shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap